OverStitch NXT Endoscopic Suturing System ESS-ESG-NXTRecalls & reported problems
Apollo Endosurgery, Inc. · Needle Driver and Anchor Exchange · Class 2
All models of OverStitch NXT Endoscopic Suturing System (2)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00811955020834), received between Jul 11, 2025 and Oct 27, 2025 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Difficult to Advance” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Advance2
- Adverse Event Without Identified Device or Use Problem1
- Detachment of Device or Device Component1
- Device-Device Incompatibility1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Perforation1
- Perforation of Esophagus1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryOct 27, 2025Device-Device Incompatibility; Device-Device Incompatibility
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OVERSTITCH NXT ENDOSCOPIC SUTURING SYSTEM WAS USED DURING AN EDG PROCEDURE ON OCTOBER 1, 2025. DURING THE PROCEDURE, THE PHYSICIAN PREPARED TO PLACE A SECOND SUTURE. TOO MUCH TISSUE WAS CAPTURED BY THE DEVICE AND THE ANCHOR EXCHANGE FAILED TO UNLOAD FROM THE NEEDLE BODY. WITH THE ANCHOR STILL IN THE PATIENT'S TISSUE, THE PHYSICIAN USED SCISSORS TO CUT THE SUTURE AND LEFT THE ANCHOR IN THE ESOPHAGEAL WALL. THE PROCEDURE WAS COMPLETED WITH MANTIS CLIPS TO FIXATE THE STENT. THERE WAS NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23389928 ↗MalfunctionSep 3, 2025Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OVERSTITCH NXT ENDOSCOPIC SUTURING SYSTEM WAS USED DURING AN ESOPHAGOGASTRODUODENOSCOPY PROCEDURE ON (B)(6) 2025. DURING THE PROCEDURE AND AFTER THE FIRST SUTURE WAS COMPLETED, THE OVERSTITCH NXT TOWER SLID FORWARD AND WAS NO LONGER TOUCHING THE DISTAL END OF THE SCOPE. A NEW OVERSTITCH NXT WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22954211 ↗InjuryAug 22, 2025Difficult to Advance; Adverse Event Without Identified Device or Use Problem; Difficult to Advance; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OVERSTITCH NXT ENDOSCOPIC SUTURING SYSTEM WAS USED DURING A STENT SUTURING PROCEDURE ON (B)(6) 2025. DURING INSERTION, THE OVERSTITCH DEVICE COULD NOT BE ADVANCED INTO THE PATIENT'S ESOPHAGUS. THE PHYSICIAN ATTEMPTED A JAW THRUST AND APPLIED EXTRA LUBE TO THE DEVICE BUT WAS STILL UNSUCCESSFUL. THEN, THE PHYSICIAN ATTEMPTED TO USE AN OVERTUBE DEVICE AND SAW A PERFORATION IN THE PATIENT'S ESOPHAGUS BELIEVED TO BE CAUSED BY THE OVERSTITCH NXT AND ABORTED THE PROCEDURE. THE PATIENT WAS ADMITTED TO THE ICU. AFTER 3 NIGHTS IN THE HOSPITAL, THE PATIENT WAS DISCHARGED.
Patient problems: Perforation
MAUDE report 22872867 ↗InjuryJul 11, 2025Difficult to Advance; Difficult to Advance
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OVERSTITCH NXT WAS USED DURING AN ENDOSCOPIC SLEEVE GASTROPLASTY PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE, THE OVERSTITCH NXT DEVICE COULD NOT BE ADVANCED INTO THE ESOPHAGUS. A DIAGNOSTIC SCOPE WAS THEN USED, WHICH REVEALED A PERFORATION JUST BELOW THE UPPER ESOPHAGEAL SPHINCTER (UES). THE PERFORATION WAS PARTIALLY CLOSED, AND THE ORIGINAL PROCEDURE WAS CANCELLED. THE PATIENT WAS ADMITTED TO THE HOSPITAL FOR OBSERVATION, AND TWO CT SCANS WERE PERFORMED. THE PATIENT WAS DISCHARGED ON (B)(6) 2025. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: Perforation of Esophagus
MAUDE report 22480861 ↗
Other Endoscopic Tissue Approximation Device devices
- Endo Stitch 173016Covidien LP · Endoscopic tissue approximation device1 death1,333 reports
- ProTack 174006Covidien LP · Endoscopic tissue approximation device709 reports
- N/A ECS29AEthicon Endo-Surgery, LLC · Endoscopic tissue approximation device1 death519 reports
- N/A ECS25AEthicon Endo-Surgery, LLC · Endoscopic tissue approximation device233 reports
- OverStitch™ M00505530Boston Scientific Corporation · Endoscopic tissue approximation device1 recall64 reports
- Polysorb 170053Covidien LP · Endoscopic tissue approximation device1 recall63 reports
- Surgidac 173024Covidien LP · Endoscopic tissue approximation device70 reports
- NA M00505550Boston Scientific Corporation · Endoscopic tissue approximation device1 recall9 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page